Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Herman

Showing results (301-310 of 892) with videos related to

Pageof 90
Sort By:
Journal of Molecular and Cellular Cardiology|September 1, 1996
Doxorubicin-induced apoptosis in spontaneously hypertensive rats: differential effects in heart, kidney and intestine, and inhibition by ICRF-187J Zhang, J R Clark, E H Herman, et al.
Diabetes Care|October 27, 2005
Does diabetes care compete with the provision of women's preventive care services?Bahman P Tabaei, William H Herman, Annissa F Jabarin, et al.
Current Diabetes Reports|July 26, 2017
Why Are Diabetes Medications So Expensive and What Can Be Done to Control Their Cost?Laura N McEwen, Sarah Stark Casagrande, Shihchen Kuo, et al.
The American Journal of Clinical Nutrition|October 1, 1975
Comparison of the adaptive changes in disaccharidase, glycolytic enzyme and fructosediphosphatase activities after intravenous and oral glucose in normal menH L Greene, F B Stifel, L Hagler, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|May 20, 2010
Does childhood overweight, parental perception of overweight, or family history of diabetes mellitus increase parental perception of type 2 diabetes risk for their child?Joyce M Lee, Susan Woolford, William H Herman, et al.
Diabetes Research and Clinical Practice|July 21, 2023
Uptake, retention, and outcomes of the National Diabetes Prevention Program by enrollee characteristics and program typeWilliam H Herman, Claudia Villatoro, Kevin L Joiner, et al.
Advances in Pharmacology and Chemotherapy|January 1, 1982
Biological properties of ICRF-159 and related bis(dioxopiperazine) compoundsE H Herman, D T Witiak, K Hellmann, et al.
Journal of Diabetes and Its Complications|August 26, 2025
Corrigendum to "Retention and outcomes of National Diabetes Prevention Program enrollees and non-enrollees with prediabetes: The University of Michigan experience" [J. Diabetes Complicat. (2023) 108527]William H Herman, Claudia Villatoro, Kevin L Joiner, et al.
Transfusion|January 25, 2014
Safety of a liberal policy for extended-date preadmission testing samplesNguyet Le, Mary E Harach, Joy M Gould, et al.
Leukemia & Lymphoma|September 13, 2006
The relevance of information generated by in vitro experimental models to clinical doxorubicin cardiotoxicitySteven E Lipshultz, Harvey Cohen, Steven D Colan, et al.
Pageof 90

Showing results (301-310 of 892) with videos related to

Sort By:
Pageof 90
Journal of Molecular and Cellular Cardiology|September 1, 1996
Doxorubicin-induced apoptosis in spontaneously hypertensive rats: differential effects in heart, kidney and intestine, and inhibition by ICRF-187J Zhang, J R Clark, E H Herman, et al.
Diabetes Care|October 27, 2005
Does diabetes care compete with the provision of women's preventive care services?Bahman P Tabaei, William H Herman, Annissa F Jabarin, et al.
Current Diabetes Reports|July 26, 2017
Why Are Diabetes Medications So Expensive and What Can Be Done to Control Their Cost?Laura N McEwen, Sarah Stark Casagrande, Shihchen Kuo, et al.
The American Journal of Clinical Nutrition|October 1, 1975
Comparison of the adaptive changes in disaccharidase, glycolytic enzyme and fructosediphosphatase activities after intravenous and oral glucose in normal menH L Greene, F B Stifel, L Hagler, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|May 20, 2010
Does childhood overweight, parental perception of overweight, or family history of diabetes mellitus increase parental perception of type 2 diabetes risk for their child?Joyce M Lee, Susan Woolford, William H Herman, et al.
Diabetes Research and Clinical Practice|July 21, 2023
Uptake, retention, and outcomes of the National Diabetes Prevention Program by enrollee characteristics and program typeWilliam H Herman, Claudia Villatoro, Kevin L Joiner, et al.
Advances in Pharmacology and Chemotherapy|January 1, 1982
Biological properties of ICRF-159 and related bis(dioxopiperazine) compoundsE H Herman, D T Witiak, K Hellmann, et al.
Journal of Diabetes and Its Complications|August 26, 2025
Corrigendum to "Retention and outcomes of National Diabetes Prevention Program enrollees and non-enrollees with prediabetes: The University of Michigan experience" [J. Diabetes Complicat. (2023) 108527]William H Herman, Claudia Villatoro, Kevin L Joiner, et al.
Transfusion|January 25, 2014
Safety of a liberal policy for extended-date preadmission testing samplesNguyet Le, Mary E Harach, Joy M Gould, et al.
Leukemia & Lymphoma|September 13, 2006
The relevance of information generated by in vitro experimental models to clinical doxorubicin cardiotoxicitySteven E Lipshultz, Harvey Cohen, Steven D Colan, et al.
Pageof 90